The role of plasma genotyping in ALK- and ROS1-rearranged lung cancer

Several subsets of non-small cell lung cancer (NSCLC) are defined by the presence of oncogenic rearrangements that result in constitutive activation of a chimeric fusion protein. In NSCLCs that harbor ALK or ROS1 rearrangements, aberrant signaling from these fusion proteins can be overcome by potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Dagogo-Jack, Ibiayi, Ritterhouse, Lauren L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article on Looking for Chimeras in NSCLC: Widen Therapeutic Options Targeting Oncogenic Fusions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815348/
https://www.ncbi.nlm.nih.gov/pubmed/33489818
http://dx.doi.org/10.21037/tlcr-2019-cnsclc-09

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815348/
https://www.ncbi.nlm.nih.gov/pubmed/33489818
http://dx.doi.org/10.21037/tlcr-2019-cnsclc-09

Ejemplares similares